Caught my eye
-
340B, Caught my eye, Drug Prices, Generics, Medicare Part D, Medicare Transaction Facilitator, Orphan Drugs, Reference Pricing, VaccinesAMP is WAC — 09/04/25
Read more: AMP is WAC — 09/04/25A Monday off is always a double win, longer weekend and shorter week. Caught My Eye Made me Laugh. 340B can be funny. Go PhRMA. Zebras, Not Unicorns. The Food and Drug Administration announced a new rare disease approval framework. While it acknowledges the challenge of rare disease, it is unclear if the new framework…
-
AMP is WAC — 8/29/25
Read more: AMP is WAC — 8/29/25It felt like a relatively quiet week. Or did I just completely jinx today? Caught my Eye Ask Me Anything. FAQs released on the 340B Model Pilot program. This is the program where manufacturers with 2026 Medicare negotiated drugs can move to a rebate program for 340B for the negotiated drugs. Manufacturers that submit plans…
-
Affordable Care Act, Caught my eye, Cell and Gene, Employers, Inflation Reduction Act, Medicaid, Medicare NegotiationAMP is WAC — 8/22/25
Read more: AMP is WAC — 8/22/25Some weeks it feels like this newsletter writes itself. This is not one of those weeks. Onward. Caught my Eye Medicaid Math. Kaiser Family Foundation has a terrific visual of how the One Big Beautiful Bill will impact the uninsured rate by state. Employer Math. Employers are expecting a big jump in premiums (9%, 7.6%…
-
Affordable Care Act, Caught my eye, Employers, Inflation Reduction Act, Medicare Negotiation, Medicare Part D, Pharmacy Benefit ManagersAMP is WAC — 08/08/25
Read more: AMP is WAC — 08/08/25If you’re off this week, excellent timing. I feel like things were sort of quiet. Or maybe that is just compared to last week. Caught my Eye Work It. I had a long post I was starting to write about health insurance in America and then I saw this NYT article and just stopped; Sarah…
-
340B, Alzheimer’s, Caught my eye, Drug Prices, Medicare Advantage, Medicare Negotiation, Medicare Part D, Medicare Transaction Facilitator, Reference PricingAMP is WAC — 08/01/25
Read more: AMP is WAC — 08/01/25Rumor has it that the weather will be cooler in the DC-area this weekend and I am giddy. Outside time sounds great – a hike, a cocktail on the patio, maybe getting the friend group together to start planning the next ski trip… hope you get a chance to dream big too. Caught my…
-
340B, Caught my eye, Drug shortages, Pharmacy Benefit Managers, Supply Chain, Utilization ManagementAMP is WAC — 7/25/25
Read more: AMP is WAC — 7/25/25Next week we’ll have our first glimpse of the Medicare Part D premiums for 2026; I expect them to be pretty awful. The Part D redesign shifted additional liability onto plans without changing enough of the premium calculation. Some articles next week will say it is unintended consequence; I think it is an intended one…
-
AMP is WAC — 7/18/25
Read more: AMP is WAC — 7/18/25I have a case of existential dread, and yet the world keeps spinning so let’s do this… Caught my Eye More Cowbell. Late last year I put out a report on biosimilars and it called out how the Inflation Reduction Act could hurt innovation and savings for biosimilars. Here is a report from Matrix Global…
-
AMP is WAC — 7/10/25
Read more: AMP is WAC — 7/10/25Last Saturday I was in the customs line in Amsterdam and the agent smirked and said, “Big Beautiful Bill, huh?” I wanted to say something, but I was mostly impressed that he was following U.S. news more closely than a lot of Americans. Caught my Eye 340No. IQVIA released a study looking at the use…
-
Affordable Care Act, Biosimilars, Caught my eye, Employers, Healthcare Costs, Inflation Reduction Act, Medicare Advantage, Medicare Part D, Pharmacy Benefit Managers, Utilization ManagementAMP is WAC — 6/27/25
Read more: AMP is WAC — 6/27/25In case you think I’m opinionated, just know that it could be so.much.worse. I often write something and then hit backspace, backspace, backspace. You’re welcome? Off next week for the 4th of July. Caught my Eye Tradeoffs. Last week USC put out a paper that reviewed how many Medicare Part D beneficiaries will likely pay…
-
AMP is WAC — 06/20/25
Read more: AMP is WAC — 06/20/25All the summer Friday vibes today, including a cocktail in mind for later. I’ve been trying to top the Paper Plane and the Broken Plane is close. Any other recs, let me know. In the meantime, to-do list in hand and ready to hit the ground running. Caught my Eye Hit Us with Your Best…
Latest news
- AMP is WAC — 03/13/26
- AMP is WAC — 3/6/26
- AMP is WAC — 02/27/26
- AMP is WAC — 2/20/26
- AMP is WAC — 2/13/26
Categories
- 340B (63)
- Affordable Care Act (22)
- Alzheimer's (11)
- Biosimilars (32)
- Caught my eye (101)
- Cell and Gene (6)
- Chevron Deference (2)
- CMMI (27)
- Copay Accumulators (7)
- COVID (3)
- Drug Prices (55)
- Drug shortages (14)
- DTC (6)
- Employers (20)
- FDA (7)
- Generics (12)
- Health Equity (4)
- Healthcare Costs (39)
- Home Health (1)
- ICER (12)
- Importation (5)
- Inflation Reduction Act (68)
- Insulin (7)
- IP (3)
- Long term care (1)
- Medicaid (22)
- Medicare Advantage (27)
- Medicare Negotiation (68)
- Medicare Part D (77)
- Medicare Transaction Facilitator (5)
- Medicare Transaction Facilitator (12)
- Obesity (27)
- On the Horizon (1)
- Orphan Drugs (8)
- Pharmacy Benefit Managers (48)
- Preventative (5)
- Reference Pricing (26)
- State-based Reform (30)
- Supply Chain (7)
- Tariffs (1)
- Uncategorized (8)
- Utilization Management (11)
- Vaccines (9)
- Value (18)